Zimmer Biomet Boosts FY23 Outlook - Update
(RTTNews) - While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) raised its adjusted earnings and revenue growth outlook for the full-year 2023.
For fiscal 2023, the company now projects adjusted earnings in a range of $7.40 to $7.50 per share on revenue growth of 5 to 6 percent from last year on a reported basis.
Previously, the company expected adjusted earnings in a range of $6.95 to $7.15 per share on projected revenue growth of 1.5 to 3.5 percent from last year on a reported basis.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.06 per share on revenue growth of 3.0 percent to $7.14 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Zimmer Biomet Trims FY24 Revenue Growth Outlook; To Acquire OrthoGrid Systems - Update
Zimmer Biomet Receives FDA's 510(k) Clearance For ROSA Shoulder System
Zimmer Biomet Guides FY24 Above Estimates - Update
Zimmer Biomet Trims FY23 Revenue Growth Outlook - Update
Zimmer Biomet Promotes COO Ivan Tornos To Succeed Bryan Hanson As President And CEO
Zimmer Biomet Receives FDA 510(k) Clearance For Identity Shoulder System
Yen Falls Amid BoJ Uncertainty
